These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8376999)

  • 21. Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion.
    Grasbon-Frodl EM; Andersson A; Brundin P
    J Neurochem; 1996 Oct; 67(4):1653-60. PubMed ID: 8858950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system.
    Hou JG; Cohen G; Mytilineou C
    J Neurochem; 1997 Jul; 69(1):76-83. PubMed ID: 9202296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons.
    Cheng N; Maeda T; Kume T; Kaneko S; Kochiyama H; Akaike A; Goshima Y; Misu Y
    Brain Res; 1996 Dec; 743(1-2):278-83. PubMed ID: 9017256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures.
    Sanchez-Ramos J; Facca A; Basit A; Song S
    Exp Neurol; 1998 Apr; 150(2):263-71. PubMed ID: 9527896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicity of glutathione depletion in mesencephalic cultures: a role for arachidonic acid and its lipoxygenase metabolites.
    Kramer BC; Yabut JA; Cheong J; Jnobaptiste R; Robakis T; Olanow CW; Mytilineou C
    Eur J Neurosci; 2004 Jan; 19(2):280-6. PubMed ID: 14725622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures.
    Mytilineou C; Kokotos Leonardi ET; Kramer BC; Jamindar T; Olanow CW
    J Neurochem; 1999 Jul; 73(1):112-9. PubMed ID: 10386961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
    Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
    Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of intracellular glutathione increases susceptibility to nitric oxide in mesencephalic dopaminergic neurons.
    Ibi M; Sawada H; Kume T; Katsuki H; Kaneko S; Shimohama S; Akaike A
    J Neurochem; 1999 Oct; 73(4):1696-703. PubMed ID: 10501217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum.
    Pileblad E; Magnusson T; Fornstedt B
    J Neurochem; 1989 Mar; 52(3):978-80. PubMed ID: 2493072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically.
    Perry TL; Yong VW; Ito M; Foulks JG; Wall RA; Godin DV; Clavier RM
    J Neurochem; 1984 Oct; 43(4):990-3. PubMed ID: 6147392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine.
    Pedrosa R; Soares-da-Silva P
    Br J Pharmacol; 2002 Dec; 137(8):1305-13. PubMed ID: 12466240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cooperative interaction between ascorbate and glutathione during mitochondrial impairment in mesencephalic cultures.
    Ehrhart J; Zeevalk GD
    J Neurochem; 2003 Sep; 86(6):1487-97. PubMed ID: 12950457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
    Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
    Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease.
    Canals S; Casarejos MJ; de Bernardo S; Rodríguez-Martín E; Mena MA
    J Neurochem; 2001 Dec; 79(6):1183-95. PubMed ID: 11752059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
    Miranda AF; Wiley MJ; Wells PG
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress.
    Mytilineou C; Walker RH; JnoBaptiste R; Olanow CW
    J Pharmacol Exp Ther; 2003 Feb; 304(2):792-800. PubMed ID: 12538835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms.
    Mena MA; Casarejos MJ; Carazo A; Paíno CL; García de Yébenes J
    J Neural Transm (Vienna); 1997; 104(4-5):317-28. PubMed ID: 9295168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors.
    Lai CT; Yu PH
    Biochem Pharmacol; 1997 Feb; 53(3):363-72. PubMed ID: 9065740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine but not l-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson's and other dopamine deficiency states.
    Allen GF; Ullah Y; Hargreaves IP; Land JM; Heales SJ
    Neurochem Int; 2013 Apr; 62(5):684-94. PubMed ID: 23261515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.